Halder Venture Issues Corrigendum for Preferential Issue of Warrants
Halder Venture Limited issues a corrigendum for its preferential issue of 7,93,650 convertible warrants at ₹315 each. Proceeds will fund capital expansion, including a 500 MT edible oil refining unit, and working capital. P.K. Bio Link Private Limited is the proposed non-promoter allottee, acquiring 5.99% post-issue.
The preferential issue of warrants at ₹315 per warrant, aimed at funding capital expansion and working capital, has a medium-term impact. The amount raised and its utilization for capacity building are significant for the company's growth prospects. The involvement of stock exchange observations and a corrigendum indicates a complex regulatory process.
The announcement is a corrigendum to a previous notice regarding a preferential issue. While it provides clarifications and details about the issue, it does not contain new positive or negative financial performance information or significant strategic shifts that would warrant a positive or negative sentiment. It is primarily a procedural update.
Halder Venture Limited has issued a corrigendum to its earlier Notice for Postal Ballot dated March 26, 2026, concerning a proposed preferential issue of convertible warrants. This corrigendum, dated April 13, 2026, is being issued in response to observations received from NSE and BSE on April 7 and April 10, 2026, respectively. The preferential issue involves 7,93,650 convertible warrants at a price of ₹315 per warrant, including a premium of ₹305. The company plans to utilize the proceeds primarily for capital expansion and expenditure, including the installation of a 500 metric ton edible oil refining unit at its Haldia Unit, and for augmenting working capital. The total estimated amount for capital expenditure is ₹11,49,99,875, and for working capital is ₹11,29,99,875. The utilization of these funds is planned within 6 months from the receipt of issue proceeds. The proposed allottee is P.K. Bio Link Private Limited, which will hold 5.99% of the post-issue fully diluted share capital and will be classified as a non-promoter. The company has obtained a valuation report from an independent registered valuer, which determined the minimum price per equity share at ₹314.79. The issue price of ₹315 per warrant has been fixed in compliance with SEBI ICDR Regulations. Shareholders who have already voted can email their comments to the Company Secretary or the scrutinizer until April 16, 2026.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.